Stay updated on Lintuzumab-Ac225 in Older AML Patients Clinical Trial
Sign up to get notified when there's something new on the Lintuzumab-Ac225 in Older AML Patients Clinical Trial page.

Latest updates to the Lintuzumab-Ac225 in Older AML Patients Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoChange DetectedThe page version was updated from v3.6.4 to v3.6.5, reflecting a new release of the page template. No study data or eligibility criteria are altered.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedRevision updated from v3.6.3 to v3.6.4, indicating a minor page/template update. No study data or eligibility details are changed.SummaryDifference0.0%

- Check46 days agoChange DetectedThe page now displays revision v3.6.3, updating from the previous v3.6.2 and signaling a refreshed publish of the study details.SummaryDifference0.0%

- Check54 days agoChange DetectedThe page displays a newer revision number (v3.6.2) replacing the previous one (v3.6.0), indicating an update to the page's version metadata.SummaryDifference0.0%

- Check68 days agoChange DetectedThe page now displays a 'No longer looking for participants' status, signaling that recruitment has closed. New navigational/help sections were added (How to Read a Study Record, Common Questions, How to Join a Study), the Intervention/Treatment label was updated, and older revision text (Revision: v3.5.5) was removed in favor of Revision: v3.6.0.SummaryDifference0.4%

- Check75 days agoChange DetectedThe page's revision label was updated from v3.5.4 to v3.5.5, indicating a backend or UI patch. No study data or public-facing content changes are reflected in this edit.SummaryDifference0.0%

Stay in the know with updates to Lintuzumab-Ac225 in Older AML Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lintuzumab-Ac225 in Older AML Patients Clinical Trial page.